FDA Panel Clears Product Path For Sanofi, Regeneron Pharmaceuticals

By: via Benzinga
A key regulatory advisory panel recommended approval of a cholesterol treatment under joint development by Sanofi SA ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.